Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues

European Journal of Immunology

Volumn 37, Issue 11, 2007, Pages 3281-3292

  Kaushansky, Nathali ^a   Zilkha Falb, Rina ^a   Hemo, Reut ^a   Lassman, Hans ^b   Eisenstein, Miriam ^a   Sas, Aldema ^a   Ben Nun, Avraham ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b Medical University of Vienna   (Austria)

Author keywords

Autoimmunity; B cells; Neuroimmunology; T cells

Indexed keywords

CYTOPLASM PROTEIN; MYELIN ASSOCIATED OLIGODENDROCYTE BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; BIOINFORMATICS; CELL SELECTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOHISTOCHEMISTRY; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDES; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 36349018864     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737438     Document Type: Article

References (50)

1. Sospedra, M. and Martin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005. 23: 683-747.
2. Kerlero de Rosbo, N., Ben-Nun, A., T cell response to myelin antigens in multiple sclerosis: Relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein. J. Autoimmun. 1998. 11: 287-299.
3. Holz, A., Schwab, M. E., Developmental expression of the myelin gene MOBP in the rat nervous system. J. Neurocytol. 1997. 26: 467-477.
4. Yamamoto, Y., Mizuno, R., Nishimura, T., Ogawa, Y., Yoshikawa, H., Fujimura, H.,Adachi, E. et al., Cloning and expression of myelin-associated oligodendrocytic basic protein. A novel basic protein constituting the central nervous system myelin. J. Biol. Chem. 1994. 269: 31725-31730.
5. Yamamoto, Y., Yoshikawa, H., Nagano, S., Kondoh, G., Sadahiro, S., Gotow, T., Yanagihara, T. and Sakoda, S., Myelin-associated oligodendrocytic basic protein is essential for normal arrangement of the radial component in central nervous system myelin. Eur. J. Neurosci. 1999. 11: 847-855.
6. Holz, A., Schaeren-Wiemers, N., Schaefer, C., Pott, U., Colello, R. J. and Schwab, M. E., Molecular and developmental characterization of novel cDNAs of the myelin-associated/oligodendrocytic basic protein. J. Neurosci. 1996. 16: 467-477.
7. Sadahiro, S., Yoshikawa, H., Yagi, N., Yamamoto, Y., Yanagihara, T., Kimura, M. and Sakoda, S., Morphometric analysis of the myelin-associated oligodendrocytic basic protein-deficient mouse reveals a possible role for myelin-associated oligodendrocytic basic protein in regulating axonal diameter. Neuroscience 2000. 98: 361-367.
8. Kaye, J. F., Kerlero de Rosbo, N., Mendel, L, Flechter, S., Hoffman, M., Yust, I., Ben-Nun, A., The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). J. Neuroimmunol. 2000. 102: 189-198.
9. de Rosbo, N. K. Kaye, J. F., Eisenstein, M., Mendel, L, Hoeftberger, R., Lassmann, H., Milo, R. and Ben-Nun, A., The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 2004. 173: 1426-1435.
10. Holz, A., Bielekova, B., Martin, R. and Oldstone, M. B., Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. J. Immunol. 2000. 164: 1103-1109.
11. Maatta, J. A., Kaldman, M. S., Sakoda, S., Salmi, A. A. and Hinkkanen, A. E., Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase for BALB/c and SJL mice. Immunology 1998. 95: 383-388.
12. Sloan-Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 1996. 14: 1-27.
13. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L. and McDevitt, H. O., T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptides. Int. Rev. Immunol. 1990. 6: 37-47.
14. Rudolph, M. G. and Wilson, I. A., The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 2002. 14: 52-65.
15. Fremont, D. H., Donnaie, D., Nelson, C. A., Hendrickson, W. A., Unanue, E. R., Crystal structure of I-Aκ in complex with dominant epitope of Isozyme. Immunity 1998. 8: 305-317.
16. Liu, X., Dai, S., Crawford, F., Fruge, R., Marrack, P. and Kappler, J., Alternate interactions define the binding of peptides to the MHC molecule IA(b). Proc. Natl. Acad. Sci. USA 2002. 99: 8820-8825.
17. Reinherz, E. L., Tan, K., Tang, L., Kern, P., Liu, J., Xiong, Y., Hussey, R. E. et al., The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999. 286: 1913-1921.
18. Hohlfeld, R. and Wekerle, H., Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc. Natl. Acad. Sci. USA 2004. 101 Suppl 2: 14599-14606.
19. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., Kuchroo, V. K., An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995. 3: 397-405.
20. Gaut, A., Boehme, S. A., Chalmers, D., Crowe, P. D., Pahuja, A., Ling, N., Brocke, S. et al., Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J. Neuroimmunol. 1997. 74: 149-158.
21. Ausubel, L. J., Krieger, J. I. and Hafler, D. A., Changes in cytokine secretion induced by altered peptide ligand of myelin basic protein peptide 85-99. J. Immunol. 1997. 59: 2502-2512
22. Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The altered peptide ligand in relapsing MS study group. Nat. Med. 2000. 6: 1176-1182.
23. Heijamns, N., Smith, P. A., Morris-Downes, M. H., Pryce, G., Baker, D., Donaldson, A. V., Hart, B. and Amor, S., Encephalitogenic and tolergenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice. J. Neuroimmunol. 2005. 167: 23-33.
24. Sloan-Lancaster, J. and Allen, P. M., Signalling events in the anergy induction of T helper 1 cells. Ciba Found. Symp. 1995. 195: 189-196; discussion 196-202.
25. +-regulated events leading to apoptosis. Proc. Natl. Acad. Sci. USA 2005. 102: 2028-2033.
26. Aruna, B. V., Ben-David, H., Sela, M. and Mozes, E., A dual altered peptide ligand down regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up regulation of Fas-Fas L-mediated apoptosis. Immunology 2006. 118: 413-424.
27. Evavold, B. D. and Allen, P. M., Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991. 252: 1308-1310.
28. Windhagen, A., Scholz, C., Hollsberg, P., Fukaura, H., Sette, A. and Hafler, D. A., Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 1995. 2: 373-380.
29. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Rocken, M., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994. 180: 1961-1966.
30. Street, N. E. and Mosmann, T. R., Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991. 5: 171-177.
31. + T cells and the control of autoimmune disease. Curr. Opin. Immunol. 2004. 16: 695-701.
32. Alleva, D. G., Gaur, A., Jin, L., Wegmann, D., Gottlieb, P. A., Pahuja, A., Johnson, E. B., Motheral, T. et al., Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 2002. 51: 2126-2134
33. Sakaguchi, S. and Sakaguchi, N., Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int. Rev. Immunol. 2005. 24: 211-226.
34. Shevach, E. M., Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 2000. 18: 423-449.
35. + T cells. Proc. Natl. Acad. Sci USA 2003. 100: 6676-6681.
36. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L. and McDevitt, H. C., Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 1989. 59: 247-255.
37. Clayton, J. P., Gammon, G. M., Ando, D. G., Kono, D. H., Hood, L. and Sercarz, E. E., Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 1989. 169: 1681-1691.
38. Gaut, A., Wiers, B., Liu, A., Rothbard, J. and Fathman, C. G., Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 1992. 258: 1491-1494.
39. Kennedy, M. K., Tan, L. J., Dal Canto, M. C., Tuohy, V. K., Lu, Z. J., Trotter, J. L. and Miller, S. D., Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J. Immunol. 1990. 144: 909-915.
40. Devaux, B., Enderlin, F., Wallner, B. and Smilek, D. E., Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. J. Neuroimmunol. 1997. 75: 169-173.
41. Bielekova, B., Goodwin, B., Richert, N., Cortese, L, Kondo, T., Afshar, G., Gran, B. et al., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 2000. 6: 1167-1175.
42. Ben-Nun, A., Kerlero de Rosbo, N., Kaushansky, N., Eisenstein, M., Cohen, L., Kaye, J. F., Mendel, I., Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. Eur. J. Immunol. 2006. 36: 478-493.
43. Kaushansky, N., Hemo, R., Eisenstein, M. and Ben-Nun, A., Oligodendrocyte-specific protein (OSP) (claudin -11)-induced EAE in C57B1 mice is mediated by pathogenic T cells primarily governed by a single epitopic residue (OSP192Y) of the major encephalitogenic region OSP179-207. Eur. J. Immunol. 2002. 37:2018-2031
44. Acha-Orbea, H., Mitchell, D. J., Timmermann, L., Wraith, D. C., Tausch, G. S., Waldor, M. K., Zamvil, S. S. et al., Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988. 54: 263-273.
45. Zhong, M. C., Cohen, L., Meshorer, A., Kerlero de Rosbo, N. and Ben-Nun, A., T cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2(b) and H-2(s) mice. J. Neuroimmunol. 2000. 105: 39-45.
46. Bruno, R., Sabater, L., Sospedra, M., Ferrer-Francesch, X., Escudero, D., Martinez-Caceres, E. and Pujol-Borrell, R., Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur. J. Immunol. 2002. 32: 2737-2747.
47. Delarasse, C., Daubas, P., Mars, L. T., Vizler, C., Litzenburger, T., Iglesias, A., Bauer, J. et al., Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Invest. 2003. 112: 544-553.
48. Kaushansky, N., Zhong, M. C., Kerlero de Rosbo, N., Hoeftberger, R., Lassmarm, H. and Ben-Nun, A., Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J. Immunol. 2006. 177: 7364-7376.
49. Greer, J. M., Kuchroo, V. K., Sobel, R. A. and Lees, M. B., Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 1992. 149: 783-788.
50. Ben-Nun, A. and Lando, Z., Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. J. Immunol. 1983. 130: 1205-1209.